Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Role of Omics in the Application of Adverse Outcome Pathways for Chemical Risk Assessment.
Brockmeier EK, Hodges G, Hutchinson TH, Butler E, Hecker M, Tollefsen KE, Garcia-Reyero N, Kille P, Becker D, Chipman K, Colbourne J, Collette TW, Cossins A, Cronin M, Graystock P, Gutsell S, Knapen D, Katsiadaki I, Lange A, Marshall S, Owen SF, Perkins EJ, Plaistow S, Schroeder A, Taylor D, Viant M, Ankley G, Falciani F. Brockmeier EK, et al. Among authors: hecker m. Toxicol Sci. 2017 Aug 1;158(2):252-262. doi: 10.1093/toxsci/kfx097. Toxicol Sci. 2017. PMID: 28525648 Free PMC article. Review.
Adverse outcome pathway (AOP) development I: strategies and principles.
Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, Ottinger MA, Vergauwen L, Whelan M. Villeneuve DL, et al. Among authors: hecker m. Toxicol Sci. 2014 Dec;142(2):312-20. doi: 10.1093/toxsci/kfu199. Toxicol Sci. 2014. PMID: 25466378 Free PMC article.
Adverse outcome pathway development II: best practices.
Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, Ottinger MA, Vergauwen L, Whelan M. Villeneuve DL, et al. Among authors: hecker m. Toxicol Sci. 2014 Dec;142(2):321-30. doi: 10.1093/toxsci/kfu200. Toxicol Sci. 2014. PMID: 25466379 Free PMC article.
Recommended approaches to the scientific evaluation of ecotoxicological hazards and risks of endocrine-active substances.
Matthiessen P, Ankley GT, Biever RC, Bjerregaard P, Borgert C, Brugger K, Blankinship A, Chambers J, Coady KK, Constantine L, Dang Z, Denslow ND, Dreier DA, Dungey S, Gray LE, Gross M, Guiney PD, Hecker M, Holbech H, Iguchi T, Kadlec S, Karouna-Renier NK, Katsiadaki I, Kawashima Y, Kloas W, Krueger H, Kumar A, Lagadic L, Leopold A, Levine SL, Maack G, Marty S, Meador J, Mihaich E, Odum J, Ortego L, Parrott J, Pickford D, Roberts M, Schaefers C, Schwarz T, Solomon K, Verslycke T, Weltje L, Wheeler JR, Williams M, Wolf JC, Yamazaki K. Matthiessen P, et al. Among authors: hecker m. Integr Environ Assess Manag. 2017 Mar;13(2):267-279. doi: 10.1002/ieam.1885. Epub 2017 Jan 27. Integr Environ Assess Manag. 2017. PMID: 28127947 Free PMC article.
Radiation adverse outcome pathways (AOPs) are on the horizon: advancing radiation protection through an international Horizon-Style exercise.
Burtt JJ, Leblanc J, Randhawa K, Ivanova A, Rudd MA, Wilkins R, Azzam EI, Hecker M, Horemans N, Vandenhove H, Adam-Guillermin C, Armant O, Klokov D, Audouze K, Kaiser JC, Moertl S, Lumniczky K, Tanaka IB 3rd, Yamada Y, Hamada N, Al-Nabulsi I, Preston RJ, Bouffler S, Applegate K, Cool D, Beaton D, Tollefsen KE, Garnier-Laplace J, Laurier D, Chauhan V. Burtt JJ, et al. Among authors: hecker m. Int J Radiat Biol. 2022;98(12):1763-1776. doi: 10.1080/09553002.2022.2121439. Epub 2022 Sep 26. Int J Radiat Biol. 2022. PMID: 36067511
1,188 results